as 11-08-2024 12:31pm EST
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.
Founded: | 2021 | Country: | United States |
Employees: | N/A | City: | WASHINGTON |
Market Cap: | 158.4M | IPO Year: | 2022 |
Target Price: | $4.50 | AVG Volume (30 days): | 7.2M |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.65 | EPS Growth: | N/A |
52 Week Low/High: | $1.09 - $9.23 | Next Earning Date: | 11-19-2024 |
Revenue: | $2,295,679 | Revenue Growth: | N/A |
Revenue Growth (this year): | 1760.86% | Revenue Growth (next year): | 314.74% |
ASPI Breaking Stock News: Dive into ASPI Ticker-Specific Updates for Smart Investing
GlobeNewswire
4 days ago
GlobeNewswire
7 days ago
GlobeNewswire
8 days ago
MT Newswires
9 days ago
The Wall Street Journal
9 days ago
GlobeNewswire
9 days ago
GlobeNewswire
9 days ago
GlobeNewswire
10 days ago
The information presented on this page, "ASPI ASP Isotopes Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.